3. Introduction
Normal cells have limited replicative potential
and have regulatory process that leads to
cell death.
All cancers contain cells that are immortal
and have limitless replicative potential.
3
5. Evasion of senescence
Normal cell Cancer cell
• Capacity to divide 60-70 times
• Accumulates DNA damage over
time
• Upregulation by p53 and INK4a
• Reach senescence
• Limitless capacity to divide
• Acquired genetic and epigenetic
aberrations
• Not regulated
• Bypass senescence
9/4/20XX Presentation Title 5
6. Evasion of mitotic crisis
• Mitotic crisis has been ascribed to progressive
shortening of telomeres special DNA sequence
at the ends of the chromosomes that bind several
types of protective protein complexes.
9/4/20XX Presentation Title 6
Cells
divide
Telomeres
shorten
Apoptosis
NORMAL CELL
9. Evasion of mitotic crisis
• In cells with dysfunctional p53, Nonhomologous
end-joining pathway (NHEJ) is activated.
• This cycle on repetition eventually produces
mitotic crisis and cell death
• In 85% to 95% of tumours it is due to the
expression of telomerase, the remaining use other
mechanisms that depends on DNA recombination.
9/4/20XX Presentation Title 9
Dysfunctional
p53
NHEJ
Pathway
Cell
death
11. Self renewal
• Self renewal means that each time a stem cell divides at least one of
the two daughter cells remains a stem cell.
9/4/20XX Presentation Title 11
Symmetrical division 2 stem cells (embryogenesis)
Asymmetrical division 1 stem cell + 1 normal cell which
undergoes apoptosis
• Example: formed elements of bone marrow and blood, epithelial
cells of GIT and skin
• Tumours too must contain cells that self-renew cancer stem cells.
12. Self renewal
9/4/20XX Presentation Title 12
• Cancer stem cells arise from both
the transformation of tissue stem
cell and from the conversion of
conventional somatic cells to
transformed cells with the acquired
property of “stemness”.
• Example: Chronic myeloid
leukemia (CML) and acute
promyelocytic leukemia.
13. Conclusion
9/4/20XX Presentation Title 13
• Cancers can repopulate their stem cell pools from non-stem cell
populations, further complicating efforts to precisely define and
selectively target cancer stem cells.
• Cancer stem cells also have high intrinsic resistance to
conventional therapies due to a low rate of cell division and the
expression of factors like multiple drug resistance-1(MDR1) that
counteract the effects of chemotherapeutic drugs